Literature DB >> 15545031

Heat inactivation of avian influenza and Newcastle disease viruses in egg products.

David E Swayne1, Joan R Beck.   

Abstract

Avian influenza (AI) and Newcastle disease (ND) viruses are heat labile viruses, but exact parameters for heat inactivation at egg pasteurization temperatures have not been established. In this study we artificially infected four egg products with two AI (one low [LP] and one high pathogenicity [HP]) and three ND (two low and one highly virulent) viruses, and determined inactivation curves at 55, 57, 59, 61 and 63 degrees C. Based on D(t) values, the time to inactivation of the viruses was dependent on virus strain and egg product, and was directly related to virus titre, but inversely related to temperature. For all temperatures, the five viruses had the most rapid and complete inactivation in 10% salt yolk, while the most resistant to inactivation was HPAI virus in dried egg white. This study demonstrated that the LPAI and all ND viruses were inactivated in all egg products when treated using industry standard pasteurization protocols. By contrast, the HPAI virus was inactivated in liquid egg products but not in dried egg whites when using the low-temperature industry pasteurization protocol.

Entities:  

Mesh:

Year:  2004        PMID: 15545031     DOI: 10.1080/03079450400003692

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  15 in total

1.  Ammonia disinfection of hatchery waste for elimination of single-stranded RNA viruses.

Authors:  Eva Emmoth; Jakob Ottoson; Ann Albihn; Sándor Belák; Björn Vinnerås
Journal:  Appl Environ Microbiol       Date:  2011-04-22       Impact factor: 4.792

2.  Composting for avian influenza virus elimination.

Authors:  Josefine Elving; Eva Emmoth; Ann Albihn; Björn Vinnerås; Jakob Ottoson
Journal:  Appl Environ Microbiol       Date:  2012-03-02       Impact factor: 4.792

3.  Importance of collection tube during clinical studies of oseltamivir.

Authors:  Niklas Lindegardh; Geraint R Davies; Tran Tinh Hien; Jeremy Farrar; Pratap Singhasivanon; Nicholas P J Day; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

4.  Comparative Study on the Efficacy of MF 59, ISA70 VG, and Nano-Aluminum Hydroxide Adjuvants, Alone and with Nano-Selenium on Humoral Immunity Induced by a Bivalent Newcastle+Avian Influenza Vaccine in Chickens.

Authors:  M Radmehri; A Talebi; A Ameghi Roudsari; S M Mousaviyan; M A J Gholipour; M Taghizadeh
Journal:  Arch Razi Inst       Date:  2021-11-30

5.  Assessment of the control measures of the Category A diseases of the Animal Health Law: prohibitions in restricted zones and risk-mitigating treatments for products of animal origin and other materials.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Karl Stahl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Kris De Clercq; Ylva Sjunnesson; Andrea Gervelmeyer; Helen Clare Roberts
Journal:  EFSA J       Date:  2022-08-09

6.  Inactivation of Viable Surrogates for the Select Agents Virulent Newcastle Disease Virus and Highly Pathogenic Avian Influenza Virus Using Either Commercial Lysis Buffer or Heat.

Authors:  Katrina Alger; Hon Ip; Jeffrey Hall; Sean Nashold; Katherine Richgels; Carrie Smith
Journal:  Appl Biosaf       Date:  2019-12-01

7.  Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling.

Authors:  Marcel Jonges; Wai Ming Liu; Erhard van der Vries; Ronald Jacobi; Inge Pronk; Claire Boog; Marion Koopmans; Adam Meijer; Ernst Soethout
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

8.  Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice.

Authors:  Eun-Ha Kim; Jun-Han Lee; Philippe Noriel Q Pascua; Min-Suk Song; Yun-Hee Baek; Hyeok-Il Kwon; Su-Jin Park; Gyo-Jin Lim; Arun Decano; Mohammed Ye Chowdhury; Su-Kyung Seo; Man Ki Song; Chul-Joong Kim; Young-Ki Choi
Journal:  Virol J       Date:  2013-04-03       Impact factor: 4.099

Review 9.  Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?

Authors:  Babak Jalilian; Stig Hill Christiansen; Halldór Bjarki Einarsson; Mehdi Rasoli Pirozyan; Eskild Petersen; Thomas Vorup-Jensen
Journal:  Mol Cell Ther       Date:  2013-11-06

10.  Inactivation of the novel avian influenza A (H7N9) virus under physical conditions or chemical agents treatment.

Authors:  Shumei Zou; Junfeng Guo; Rongbao Gao; Libo Dong; Jianfang Zhou; Ye Zhang; Jie Dong; Hong Bo; Kun Qin; Yuelong Shu
Journal:  Virol J       Date:  2013-09-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.